Document Detail


Co-existence of kindling induced by the beta-carboline, FG 7142, and tolerance to diazepam following chronic treatment in mice.
MedLine Citation:
PMID:  2846325     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of chronic treatment with the beta-carboline, FG 7142, followed by chronic treatment with diazepam (DZP) on the acute effects of DZP and FG 7142 were studied. Mice were treated for 16 days with FG 7142 (40 mg/kg i.p.) followed by treatment with DZP (5 or 20 mg/kg i.p.) for 9 days. At the end of this period, the anticonvulsant, antipunishment and locomotor sedative properties of a test dose of DZP were assessed, as were the convulsant properties of FG 7142. During the chronic treatment with FG 7142, 80% of the mice developed clonic convulsions in response to the beta-carboline, and this increased sensitivity to FG 7142 (kindling) remained following the chronic DZP treatment. Thus long-term treatment with DZP does not reverse the changes which occur during FG 7142-induced kindling. Chronic treatment with DZP for 9 days gave rise to tolerance to its pharmacological effects as assessed in the 4-plate test of antipunishment activity, in a test of locomotor sedation, and by its ability to increase the convulsant threshold of intravenously administered pentylenetetrazol. The development of tolerance to DZP was not affected by a prior chronic treatment with FG 7142. Nor were the acute effects induced by DZP altered by a prior chronic treatment with FG 7142. Apart from reducing its own convulsant threshold, chronic treatment with FG 7142 had no effect in any of the experiments. These results suggest that kindling induced by FG 7142 and tolerance to DZP depend on different mechanisms. In neither case were the pharmacological changes induced by chronic administration reflected by changes in the biochemical measures of the coupling between benzodiazepine binding sites and gamma-aminobutyric acid (GABA) receptors.
Authors:
H H Schneider; D N Stephens
Related Documents :
16416305 - Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and qu...
17613965 - Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe a...
7906655 - Anxiolytic activity of tachykinin nk2 receptor antagonists in the mouse light-dark box.
7875235 - Felbamate antagonizes isoniazid- and fg 7142-induced reduction of gabaa receptor functi...
10968685 - A trial of two iron-dextran infusion regimens in chronic hemodialysis patients.
2040325 - Persistent inhibition of platelet function during long-term treatment with 75 mg acetyl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pharmacology     Volume:  154     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1988 Sep 
Date Detail:
Created Date:  1988-12-01     Completed Date:  1988-12-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  35-45     Citation Subset:  IM    
Affiliation:
Research Laboratories of Schering AG, Berlin, F.R.G.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Anxiety Agents*
Benzodiazepines*
Carbolines / pharmacology*
Diazepam / pharmacology*
Drug Tolerance
Female
Kindling, Neurologic / drug effects*
Lorazepam / analogs & derivatives,  metabolism
Mice
Motor Activity / drug effects
Punishment
Receptors, GABA-A / drug effects
Seizures / chemically induced
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 0/Carbolines; 0/Receptors, GABA-A; 12794-10-4/Benzodiazepines; 439-14-5/Diazepam; 78538-74-6/FG 7142; 846-49-1/Lorazepam; 848-75-9/lormetazepam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtyp...
Next Document:  Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets.